Oruka Therapeutics, Inc.

ORKA

—

Advanced chart & tools →

Oruka Therapeutics, Inc.ORKA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.87

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

Net income

$-105.43M

Net margin

—

Gross margin

—

Dividends & financials

Oruka Therapeutics, Inc. (ORKA) reported revenue of $0 and net income of $-105.43M, or $-3.87 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.